MYF5 and chronic kidney disease: Again, we think it is reasonable to suggest that, at least in part, this elevation in Myf‐5 in CKD myoblasts is an epigenetic adaptation, in response to the predisposition of these cells to a uraemic environment, although detailed epigenetic deep dive analysis is required to confirm this.